LOKON PHARMA is a Swedish biotech company in the forefront of developing immunostimulatory gene therapy for cancer-based on oncolytic viruses. Innovative gene engineering, solid expertise in cancer biology and immunology, as well as a genuine curiosity in life science expand Lokon’s pipeline towards groundbreaking new therapeutics for patients with high unmet medical need.
View Top Employees from Lokon Pharma ABWebsite | http://lokonpharma.com |
Revenue | $1 million |
Employees | 10 (8 on RocketReach) |
Founded | 2011 |
Address | 14 Bredgränd, Uppsala, Uppsala 753 20, SE |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Biotechnology, Pharmaceuticals, Manufacturing, Science and Engineering, Distributors/Wholesale, Therapeutics, Health Care |
SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Lokon Pharma AB employee's phone or email?
The Lokon Pharma AB annual revenue was $1 million in 2024.
Titti Björnström is the Head of QA and QC of Lokon Pharma AB.
8 people are employed at Lokon Pharma AB.
Lokon Pharma AB is based in Uppsala, Uppsala.
The NAICS codes for Lokon Pharma AB are [32, 3254, 325].
The SIC codes for Lokon Pharma AB are [28, 80, 283].